Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Life Sciences Partners

Life Sciences Partners
VC INVESTOR TYPE
Active STATUS
17 PROFESSIONALS
170 INVESTMENTS
38 PORTFOLIO
79 EXITS
Description

Founded in 1998, Life Sciences Partners is a venture capital firm based in Amsterdam, The Netherlands. The firm seeks to make minority seed, early-stage, and later-stage investments. The firm prefers to invest in the pharmaceuticals, biotechnology and life sciences sectors in the United States and Western Europe.

Website
Investor Status
Actively Seeking New Investments
Trade Association
Principles for Responsible Investment (PRI)
Year Founded
1998
Primary Investor Type
Venture Capital
Other Investor Types
Accelerator/Incubator
Impact Investing
Primary Office
  • Johannes Vermeerplein 9
  • 1071 DV Amsterdam
  • Netherlands

+31 020 000 0000

Life Sciences Partners Investments (170)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
ImCheck Therapeutics 04-Dec-2019 Early Stage VC 0000 Biotechnology Startup 0000000 00000000 00.0
0000000000 01-Oct-2019 00000 00000 0000 Monitoring Equipment Generating Revenue 00000 00000 00.0
000000000 10-Sep-2019 00000 00000 0000 Drug Discovery Startup 0000000 000000000
000000 05-Sep-2019 00000 00000 000.00 Therapeutic Devices Clinical Trials - General 0000000 000 000000000000 00.0
00000 0000000 05-Sep-2019 00000 00000 000.00 Surgical Devices Generating Revenue/Not Profitable 0000 00000000 00.0
000000 00000000000 04-Sep-2019 00000 00000 00000 Biotechnology Generating Revenue 00000 00000 00.0
0000é 000000 0 25-Jul-2019 00000 00000 000.00 Drug Discovery Startup 000000 0000000-000 000000
00-000000 16-Jul-2019 00000 00000 00000 Biotechnology Clinical Trials - Phase 2 0000000 000000000
ImCyse 18-Jun-2019 Later Stage VC 000.00 Biotechnology Clinical Trials - Phase 2 0000 00000000 00.0
DNA Script 15-May-2019 Early Stage VC 000.00 Biotechnology Generating Revenue 0000000 00000 00.0
To view this investor’s complete investment and acquisition history, request access »
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Life Sciences Partners’s full profile, request a free trial.

Life Sciences Partners Exits (79)

Company Name Exit Date Exit Type Exit Size Status Buyers
Immunic Therapeutics 12-Apr-2019 Reverse Merger Completed
00000000000000 07-Feb-2019 000 000.00 Completed
0000000 31-Jul-2018 000000000000000000 00000 Completed
  • 000000 00000000000
0000000 0000000 26-Apr-2018 000000000000000000 Completed
  • 000000000 00000000
0000000 0000000 25-Apr-2018 0000000000: 000000 Completed
00000 000000000000 19-Dec-2017 0000000 000000 Completed
000000 14-Dec-2017 000000 0000000000 00000 Completed
00000000 0000000 06-Dec-2017 000000000000000000 00000 Completed
  • 00000 & 000000
Orphazyme 21-Nov-2017 IPO 000.00 Completed
  • 4 buyers
Argenx 18-May-2017 Public Investment 2nd Offering 00000 Completed
To view this investor’s complete exits history, request access »

Life Sciences Partners Team (30)

Name Title Deals Funds Boards Office Contact
Info
Merijn Klaassen Chief Financial Officer & Partner Amsterdam, Netherlands
Martijn Kleijwegt Founder, Co-Owner & Managing Partner 00 0 0 Amsterdam, Netherlands
Mark Wegter Managing Partner & Co-Owner 0 0 Amsterdam, Netherlands
Rene Kuijten Ph.D Managing Partner & Co-Owner 00 0 0 Amsterdam, Netherlands
Rudy Dekeyser Ph.D Managing Partner 0 0 0 Amsterdam, Netherlands

8 Former Team Members

You’re viewing 5 of 30 team members. Get the full list »